NCT07140406Active, not recruiting
Observation of the Therapeutic Effect of Fire Needle on Upper Limb Function in Stroke Patients
Three-dimensional Motion Capture System Combined With sEMG Was Used to Evaluate the Effect of Different Firebone Acupuncture Strategies on Upper Limb Function in Stroke Patients
Source: ClinicalTrials.gov · Last updated 24 Aug 2025
Brief summary (registry, in English)
Objective: To explore the clinical efficacy of different needling strategies with moxibustion needles on upper limb function in post-stroke patients. Method: 105 patients with upper limb dysfunction after stroke were randomly divided into an extensor treatment group, a flexor treatment group, and a control group, with 35 patients in each group. Patients in the extensor treatment group were treated with extensor group moxibustion, patients in the flexor treatment group were treated with flexor group moxibustion, and patients in the control group were treated with conventional moxibustion. Observe the upper limb movement trajectory, surface electromyographic signals (sEMG) of extensor and flexor muscle groups, MAS scale scores, and FMA-UE scores of two groups of patients under specific tasks detected by a three-dimensional motion capture system before and after treatment, and determine the clinical efficacy. Result: Moxibustion therapy with moxibustion is helpful in improving upper limb dysfunction in stroke patients, safe and reliable, and worthy of application. The efficacy of needling the flexor muscle group with moxibustion is better than that of needling the extensor muscle group and conventional acupuncture, providing certain evidence and guidance for the selection of moxibustion sites in clinical practice.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 105 (estimated)
- First submitted
- 28 Jul 2025
- Start date
- 2 Dec 2023
- Primary completion date
- 30 Sept 2025
- Lead sponsor
- Qilu Hospital of Shandong University
- Diseases
- Stroke
- NCT number
- NCT07140406
What you commit to
- Study type: Interventional
- Planned participants: 105
- From 2 Dec 2023 to the primary completion date, 30 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Bilateral disease.
- History of serious injury or disease of other upper limb nerves muscles or bones.
- Patients with severe cervical spondylosis and hypertension.
- Patients with audiovisual abnormalities severe cognitive impairment and mental diseases who cannot cooperate with the examination.
- There are contraindications for needle treatment such as extreme hunger tension infectious diseases skin collapse etc.
Other
- Patients with tumor and severe malnutrition.
Who the study is looking for
- Meet the diagnostic criteria.
- The patient had a first stroke and the course of disease was 15 days to 12 months.
- With unilateral disease， the muscular tone assessed by the modified Ashworth scale of upper limb was Ⅰ/Ⅰ+/Ⅱ/Ⅲ level ，Brunnstrom stage in upper limb was Ⅲ/Ⅳ/Ⅴ， Upper limb muscle strength is greater than or equal to grade 2.
- Age 18-70 years old.
- Have not taken Chinese or Western medicine sedatives muscle relaxants or any drugs that have an impact on muscle tone recently.
- Clear consciousness stable vital signs no other acute diseases and serious complications.
- Patients or family members agree to accept this clinical study and have signed informed consent.
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Qilu Hospital of Shandong University Coordinator of this site? Confirm its status | Jinan | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.